Epigenetics in renal cell cancer: mechanisms and clinical applications

SC Joosten, KM Smits, MJ Aarts, V Melotte… - Nature Reviews …, 2018 - nature.com
Renal cell carcinoma (RCC) is characterized by an infrequent number of somatic mutations.
By contrast, epigenetic aberrations are commonly found in RCC, indicating that epigenetic …

A comprehensive review of lysine-specific demethylase 1 and its roles in cancer

A Hosseini, S Minucci - Epigenomics, 2017 - Taylor & Francis
Histone methylation plays a key role in the regulation of chromatin structure, and its
dynamics regulates important cellular processes. The investigation of the role of alterations …

CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth

L Xu, X Feng, X Hao, P Wang, Y Zhang… - Journal of Experimental …, 2019 - Springer
Abstract Background Circular RNAs (circRNAs) play important roles in tumourigenesis and
tumour progression. However, the expression profiles and functions of circRNAs in …

SETD3 protein is the actin-specific histidine N-methyltransferase

S Kwiatkowski, AK Seliga, D Vertommen, M Terreri… - Elife, 2018 - elifesciences.org
Protein histidine methylation is a rare post-translational modification of unknown
biochemical importance. In vertebrates, only a few methylhistidine-containing proteins have …

Histone methyltransferase SMYD2: ubiquitous regulator of disease

X Yi, XJ Jiang, ZM Fang - Clinical Epigenetics, 2019 - Springer
SET (Suppressor of variegation, Enhancer of Zeste, Trithorax) and MYND (Myeloid-Nervy-
DEAF1) domain-containing protein 2 (SMYD2) is a protein methyltransferase that methylates …

[HTML][HTML] Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma

L Yan, B Ding, H Liu, Y Zhang, J Zeng, J Hu, W Yao… - Theranostics, 2019 - ncbi.nlm.nih.gov
SMYD2 is a histone methyltransferase that has been reported to be an important epigenetic
regulator. This study aims to investigate SMYD2 as a prognostic indicator of clear cell renal …

Histone methyltransferases as therapeutic targets for kidney diseases

C Yu, S Zhuang - Frontiers in pharmacology, 2019 - frontiersin.org
Emerging evidence has demonstrated that epigenetic regulation plays a vital role in gene
expression under normal and pathological conditions. Alterations in the expression and …

Histone H3K4 methyltransferases as targets for drug-resistant cancers

L Yang, M Jin, KW Jeong - Biology, 2021 - mdpi.com
Simple Summary Epigenetic modifications can regulate gene expression by altering
chromatin structure. Since the beginning of comprehensive research into changes in gene …

Dynamic regulation of epigenetic demethylation by oxygen availability and cellular redox

N Lamadema, S Burr, AC Brewer - Free Radical Biology and Medicine, 2019 - Elsevier
The chromatin structure of the mammalian genome must facilitate both precisely-controlled
DNA replication together with tightly-regulated gene transcription. This necessarily involves …

SETD3 is a positive regulator of DNA-damage-induced apoptosis

E Abaev-Schneiderman, L Admoni-Elisha… - Cell death & disease, 2019 - nature.com
SETD3 is a member of the protein lysine methyltransferase (PKMT) family, which catalyzes
the addition of methyl group to lysine residues. However, the protein network and the …